Literature DB >> 8310969

Treatment of migraine: a new era.

M J Hoffert1.   

Abstract

Current research has refuted the vascular theory of migraine. New insights into the phenomenon of migraine are leading to alternative treatments. Sumatriptan is the first of many new drugs that will augment the treatment of migraine. High cost may limit the use of some new drugs.

Entities:  

Mesh:

Year:  1994        PMID: 8310969

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  1 in total

1.  Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine.

Authors:  K W Evans; J A Boan; J L Evans; A Shuaib
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.